When governments become top shareholders, corporate focus shifts from pleasing customers to securing political favor and appropriations. R&D budgets are reallocated to lobbying, and market competition devolves from building the best product to playing the policy game most effectively, strangling innovation.

These terms are not interchangeable. 'Pro-business' policies often protect incumbents through regulation, leading to cronyism and cartels. 'Pro-market' policies foster open competition, which is the best defense against corporate corruption and monopolies.

The narrative of AI doom isn't just organic panic. It's being leveraged by established players who are actively seeking "regulatory capture." They aim to create a cartel that chokes off innovation from startups right from the start.

Overly complex building regulations result in regulatory capture. Only large, well-connected developers can navigate the system, creating a moat that stifles competition from smaller innovators and keeps prices artificially high for consumers.

From Trump's endorsement of media mergers that benefit him to politically motivated FCC probes, regulatory agencies are being weaponized. Their purpose is shifting from independent review for consumer benefit to tools for rewarding allies and punishing political enemies.

Bill Gurley voices concern that large AI companies like Anthropic, which are lobbying heavily, might be using regulation as a competitive weapon. This "regulatory capture" tactic would create high barriers to entry, stifling innovation from smaller startups and open-source projects, effectively "pulling up the ladder" behind them.

Leading AI companies allegedly stoke fears of existential risk not for safety, but as a deliberate strategy to achieve regulatory capture. By promoting scary narratives, they advocate for complex pre-approval systems that would create insurmountable barriers for new startups, cementing their own market dominance.

Venture capitalist Bill Gurley explains "regulatory capture" as a phenomenon where established companies influence regulations to their own benefit. This tactic is used not for public good, but to block new competitors, raise prices, and solidify market dominance, particularly in industries like healthcare and finance.

Regulatory capture is not an abstract problem. It has tangible negative consequences for everyday consumers, such as the elimination of free checking accounts after the Dodd-Frank Act was passed, or rules preventing physicians from opening new hospitals, which stifles competition and drives up costs.